Pheochromocytoma-induced cardiogenic shock rescued by percutaneous cardiopulmonary bypass system.
Pheochromocytoma is a rare cause of cardiogenic shock. Clinical management is directed at reducing the heart rate while maintaining blood pressure. However, medical treatment is often unsuccessful because of the high endogenous catecholamine level and low cardiac output. Percutaneous cardiopulmonary bypass system is a circulatory device that allows for safer use of heart-rate-reducing agents, which is advantageous when used early in the course of the cardiogenic shock induced by pheochromocytoma.
Park
Sung-Min
SM
Department of Thoracic and Cardiovascular Surgery, Kyung Hee University East-West Neo Medical Center, Seoul, Korea. heartlung@gmail.com
Kim
Dae-Hyun
DH
Kwak
Young-Tae
YT
Jeong
In-Kyung
IK
Cho
Jin-Man
JM
Jin
Eun-Sun
ES
Kim
Chong-Jin
CJ
D000310:Adrenal Gland Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery; D000315:Adrenalectomy; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001794:Blood Pressure; D002315:Cardiopulmonary Bypass; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004562:Electrocardiography; D005263:Femoral Artery; D005268:Femoral Vein; D006339:Heart Rate; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D008297:Male; D010673:Pheochromocytoma / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery; D011654:Pulmonary Edema / Q000209:etiology / Q000628:therapy; D012770:Shock, Cardiogenic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D004232:Diuretics